Abstract
Dolutegravir/rilpivirine (Juluca(A (R))) is the first two-drug single-tablet regimen (STR) to be approved for the treatment of HIV-1 infection in adul......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
